论文部分内容阅读
日本武田制药公司1987年春正式聘用了两名取得哲学博士学位的外籍研究人员,正式雇用外籍研究人员在制药界这还是第一次。武田制药公司是想将此行动成为刺激剂之一,从内部促使研究开发国际化。M.Harcourt 是在爱尔兰都柏林大学取得合成化学方面的哲学博士学位的,3月1日进入武田公司工作,今后两年间,参加糖尿病治疗药的化学合成等研究。还有1人是取得英国约克大学哲学博士学位的 D.G.Cork。Cork 本身是从事回旋加速器核医学研究的,现在承担开发利用正电子放射断层摄影装置(PET)时所用的放射性医药品的自动合成装置
In the spring of 1987, Japan Takeda Pharmaceutical Co., Ltd. officially employed two foreign researchers who obtained a Ph.D. in philosophy and formally employed foreign researchers for the first time in the pharmaceutical industry. Takeda Pharmaceutical Co., Ltd. wants to make this action one of the stimulators, and promotes the internationalization of research and development from within. M. Harcourt obtained his Ph.D. in synthetic chemistry from the University of Dublin, Ireland. He joined the Takeda company on March 1 and will take part in the chemical synthesis of diabetes treatment drugs for the next two years. Another is D.G.Cork, who obtained a Ph.D. in philosophy from the University of York. Cork is engaged in cyclotron nuclear medicine research and now undertakes an automatic synthesis device for the development of radiopharmaceuticals used in the use of PET.